Biomarkers (2)
- AFP - Serum alpha fetoprotein level (phv00407033.v1.p1)
- CP_Score - Child-Pugh Score (phv00407034.v1.p1)
Demographics (2)
- Age - Age at treatment (phv00407027.v1.p1)
- gender - Sex of patient (phv00407031.v1.p1)
Disease Events (3)
- AFFECTION_STATUS - Case control status of the subject for hepatocellular carcinoma (phv00407023.v1.p1)
- censored_1 - Censored survival status at follow_up (phv00407028.v1.p1)
- censoring_days - Number of follow-up days from surgery (phv00407029.v1.p1)
Other (14)
- ANALYTE_TYPE - Analyte Type (phv00407039.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00407038.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00407022.v1.p1)
- fch_uptake - Fluorocholine uptake on PET/CT (phv00407030.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00407041.v1.p1)
- IS_TUMOR - Tumor status (phv00407040.v1.p1)
- MVI - Microvascular invasion detected in specimen (phv00407035.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00407042.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00407037.v1.p1)
- SAMPLE_ID - Sample ID (phv00407025.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00407026.v1.p1)
- SUBJECT_ID - Subject ID (phv00407021.v1.p1)
- SUBJECT_ID - Subject ID (phv00407024.v1.p1)
- tumor_size - Tumor size (greater or less than 4 cm) (phv00407036.v1.p1)